Firma Fresenius Medical Care AG & Co. KGaA, Autor bei PR-Web

Fresenius Medical Care revises financial outlook for full year 2022 due to delayed effects from improvements in North American Services business in challenging environment

Posted on 31. October 2022 by Firma Fresenius Medical Care AG & Co. KGaA Posted in General Tagged clinical, dialysis, energy, fme25, fresenius, humacyte, interwell, items1, market, patients, revenue, securities, statements, tax, with

– Business development continues to be strongly impacted by highly uncertain macroeconomic environment driving wage and general cost inflation in all reporting segments – Impacts of improvements in North American Health Care Services operations delayed – COVID-19-related excess mortality in […]

Fresenius Medical Care publishes financial results for the second quarter and first half of 2022 in line with preliminary results

Posted on 2. August 2022 by Firma Fresenius Medical Care AG & Co. KGaA Posted in General Tagged cares, clinical, dialysis, energy, fme25, fresenius, humacyte, market, new, patients, renal, revenue, securities, statements, with

. – Results unchanged compared with preliminary figures published on July 27, 2022 – Business development impacted by unprecedented U.S. labor market situation and worsening macroeconomic environment driving cost inflation and supply chain disruptions – Meaningful decline in COVID-19-related excess […]

Fresenius Medical Care: Growth drivers remain unchanged, Annual General Meeting approves 25th consecutive dividend increase

Posted on 12. May 202213. May 2022 by Firma Fresenius Medical Care AG & Co. KGaA Posted in General Tagged cares, clinical, dialysis, dividend, fiscal, fme25, fresenius, patients, renal, report, revenue, securities, statements, supervisory, with

Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, is returning to a growth path after the significant burdens of the COVID-19 pandemic. At today’s Annual General Meeting, Chief Executive Officer Rice Powell […]

Fresenius Medical Care reports first quarter results in line with its expectations despite significant headwinds

Posted on 4. May 20225. May 2022 by Firma Fresenius Medical Care AG & Co. KGaA Posted in General Tagged cares, clinical, dialysis, fme25, forwardlooking, fresenius, market, patients, renal, revenue, securities, statements, strong, treatment, with

. – Higher than anticipated COVID-19-related excess mortality, but declining throughout the quarter – Earnings development affected by ongoing significantly elevated labor costs compounded by effects from Omicron in Health Care Services and by increased material and logistics costs in […]

Dr. Carla Kriwet to succeed Rice Powell as Chief Executive Officer of Fresenius Medical Care

Posted on 4. May 20224. May 2022 by Firma Fresenius Medical Care AG & Co. KGaA Posted in General Tagged abb, Benz, bsh, clinical, dialysis, fresenius, kriwet, linde, patients, philips, project, securities, sos, statements, with

Dr. Carla Kriwet (51) will become the new CEO of Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, on January 1, 2023. The Supervisory Board of Fresenius Medical Care Management AG unanimously […]

Fresenius Medical Care receives FDA clearance for Versi™PD Cycler System

Posted on 21. April 202221. April 2022 by Firma Fresenius Medical Care AG & Co. KGaA Posted in General Tagged apd, battery, clinical, dialysis, embedded, fresenius, kidney, liberty, patients, renal, securities, statements, therapy, versipd, with

Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, announced today that the U.S. Food and Drug Administration (FDA) has awarded 510(k) clearance to the Versi™PD Cycler System1. This next-generation portable automated peritoneal […]